Summary
Amos Folarin is a biotech-focused software leader and entrepreneur with 13 years of experience combining bioinformatics, high-throughput data analysis and software delivery to drive target discovery and translational research. As Co-Founder & CEO of Onsentia and former Informatics Software Development Group Leader at SLaM/Kings College London, he has led cross-disciplinary teams building pipelines and platforms that integrate genomics, proteomics, clinical records and wearable data to discover biomarkers and predict disease trajectories. His background—PhD in Computational Systems Biology from UCL and an MRes in Bioinformatics—underpins a hands-on approach to architecting scalable analysis systems, managing HPC, and securing research funding. Notably, his early work at Inpharmatica yielded patented discoveries of novel human adenylyl cyclases, reflecting a track record that spans both wet-lab insight and software innovation. Based in London, he sits at the intersection of health and technology, focusing on turning complex biomedical data into actionable clinical intelligence.
13 years of coding experience
16 years of employment as a software developer
MRes, Bioinformatics, Distinction, MRes, Bioinformatics, Distinction at Birkbeck College, University of London
PhD, Computational Systems Biology, PhD, Computational Systems Biology at University College London (UCL).
Biochemistry with Molecular Biology and Biotech., Biology, Upper Second, Biochemistry with Molecular Biology and Biotech., Biology, Upper Second at University of Bristol